Please login to the form below

Not currently logged in
Email:
Password:

Veklury

This page shows the latest Veklury news and features for those working in and with pharma, biotech and healthcare.

Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM

Questions surrounding remdesivir treatment for COVID-19 are ‘complicated’, says NEJM

In October, the US Food and Drug Administration (FDA) approved remdesivir under the brand name Veklury for the treatment of hospitalised COVID-19 patients, based on the ACTT-1 trial data.

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...

Infographics